Molecular Diagnostics
Genomic Testing to Help Better Assess and Treat Heart Disease Patients
Cardiovascular disease is the primary cause of death worldwide, with genetics playing a crucial role in determining a patient's risk and response to common medications. A series of clinical studies will now evaluate the effects of comprehensive genomic testing in various disease areas. More...12 Apr 2023
Next-Generation Diagnostic Test Predicts Drug Responses to Enable More Precise Cancer Therapy
A next-generation diagnostic test predicts drug responses by integrating cancer genomics knowledge with drug sensitivity testing of patient-derived live cells, combined with robotics and proprietary algorithms. More...11 Apr 2023
Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care
A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of tests. The pocket-sized lab can perform multiple biological analyses from just a finger prick of blood and send the results via Bluetooth to a smartphone or tablet. More...10 Apr 2023
New Blood Test Identifies Type 2 Diabetes Risk by Analyzing DNA Changes
A new study indicates that by analyzing changes in the DNA present in blood samples, it is possible to significantly improve the ability to predict the likelihood of an individual developing type 2 diabetes within a decade. More...07 Apr 2023
Breast Cancer Subtyping Assay on Rapid MDx Platform to Deliver Fastest Time to Results
Biocartis Group NV and APIS Assay Technologies Ltd. have entered into a new partnership agreement for the development of APIS’ Breast Cancer Subtyping assay on Biocartis’ rapid and easy-to-use molecular diagnostics platform Idylla. More...07 Apr 2023
Blood-Based Biomarkers Detectable by Simple Blood Test Could Simplify Diagnosis of Alzheimer's
A new study has demonstrated that blood-based biomarkers for amyloid and tau are highly correlated with the established biomarkers used for Alzheimer's diagnosis. These blood-based biomarkers have also shown great diagnostic accuracy in distinguishing between normal and non-normal levels of amyloid and tau biomarkers. More...06 Apr 2023
Benchtop Automated ELISA Platform Achieves Consistent Biomarker Detection 
The Ella automated immunoassay instrument from Bio-Techne Corporation streamlines the laborious manual process associated with traditional immunoassays, delivering quicker results, increased lab efficiency and reduced human error. More...
06 Apr 2023
Gold Member
Turnkey Packaging Solution
HLX
 Rapid Test.jpg)
New
Clostridium Difficile Test
VIDITEST C. Difficile Toxin A+B (Card) Rapid Test
New
Vedolizumab ELISA
RIDASCREEN VDZ Monitoring
In Other News
Next-Gen IVD LC-MS/MS System 5X More Sensitive for Quantifying Analytes in Saliva, Breath and Dried Blood Spots
Easy-to-Administer Blood Test Could Enable High-Risk Lung Cancer Screening
Real-Time Quick-Response PCR Test Marks First Real Innovation in Subtyping Breast Cancer in Decades
Testing for Biomarkers in Urine and Blood Can Predict Patient’s Risk of Developing Chronic Kidney Disease
Non-Invasive Diagnostic Test Improves Detection of Oral Cancer
Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets
New Integrated PCR Solutions Offer Flexibility and Portability for Small Laboratories and On-Site Testing
Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment
Blood Test for Multiple Pathways Related to Alzheimer’s Could Enable Earlier and Less-Invasive Diagnosis
POC Test Detects Genetic Blood Disorders with High Accuracy
Non-Invasive Fecal DNA Test Accurately Detects Colorectal Cancer and Precancerous Lesions
Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office
Serum Protein Test Can Predict Outcomes for Liver Failure Patients
Fully Automated Blood-Based Assays Measure Biomarker for Neurodegenerative Diseases within 35 Minutes
POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds
Transformative NGS Innovation Expands Access to Genomic Testing for Tuberculosis Patients
Quick, Affordable Finger-Prick Test Diagnoses Common STI in Five Minutes
Automated Sample-to-Result PCR Test Enables Rapid Genotyping for Antiplatelet Therapy
Handheld Molecular POCT System Enables Rapid Onsite Testing at Hospital ERs and Clinics
Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment
Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting
First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer
Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
